Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs +/- Cord Blood for Graft Failure after Auto-HSCT
NCT01763099Phase 2Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mesenchymal stem cells in Graft failure (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Hematopoietic recovery at 1 year. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
Graft failure
Beyond the preview
Go deeper on NCT01763099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763099.